Notice about shortage of Androgel 50 mg, gel in sachet (testosterone)
The marketing authorisation holder for the medicinal product Androgel 50 mg, gel in sachet (testosterone), Hospitalija trgovina d.o.o. has informed the Agency for Medicinal Products and Medical Devices (HALMED) about the shortage of this medicine on the Croatian market. The shortage is due to a manufacturing delay.
The normalisation of the supply chain is expected in the middle of July.
Taking account that there is no other medicinal product with the same pharmaceutical form, same active substance in the Republic of Croatia and in order to ensure an adequate and continued market supply with this medicine, the marketing authorisation holder will ensure a sufficient quantity of this medicine from another market with a partial approval from HALMED for legal exemption from the labelling and package leaflet in the Croatian language.